blepharitis
BLEPHARITIS
Blepharitis is an inflammation process affecting the eyelid margins, eyelash follicles or openings of the anteriorly-placed accessory lacrimal glands and the posteriorly-placed Meibomian glands that causes ocular irritation and redness acutely but usually chronically.
It may have periods of exacerbations and remissions.
It usually occurs in middle-aged adults but can also start in childhood.
Can affect vision by disrupting the surface of the cornea and the bulbar conjunctiva; may influence tear film composition.

Blepharitis Drug Information

Drug Information

Indication: Purulent bacterial & trachomatous conjunctivitis caused by Chlamydia trachomatis in adults & childn fr...

Indication: Ophth Conjunctivitis, corneal injuries, superficial punctuate keratitis, vernal keratoconjunctivitis. Adjunct ...

Indication: Ocular infections involving conjunctiva &/or cornea due to susceptible organisms.

Indication: Bacterial conjunctivitis.

Indication: Local treatment for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated ...

Indication: Bacterial eye infections caused by susceptible organisms in conjunctivitis, blepharitis, sty, keratitis, dacry...

Indication: Ocular infections involving conjunctiva &/or cornea caused by chlorampenicol-susceptible organisms

Indication: Fungal blepharitis, conjunctivitis & keratitis caused by susceptible organisms.

Neo-Deca
dexamethasone sodium phosphate + neomycin sulfate

Indication: Acute steroid-responsive inflammatory & allergic conditions w/ accompanying bacterial infections.

1  /  4
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.